학술논문

The Lifelong Burden of Homozygous Familial Hypercholesterolemia
Document Type
Article
Source
Canadian Journal of Cardiology; October 2019, Vol. 35 Issue: 10 p1419.e1-1419.e4, 4p
Subject
Language
ISSN
0828282X
Abstract
Homozygous familial hypercholesterolemia is caused by mutations in the low-density lipoprotein receptor gene. It is diagnosed in children or youth who present with extensive tendinous and cutaneous xanthomas and extreme elevation of low-density lipoprotein cholesterol. Untreated, premature coronary artery disease develops in the teenage years or earlier and survival to ages older than 30 years is rare. Herein we describe the clinical course of a patient with homozygous familial hypercholesterolemia treated according to the standards of care and experimental approaches. Despite aggressive therapies, atherosclerosis in all vascular beds progressed, leading to the patient’s demise at age 59 years, highlighting the importance of early diagnosis and appropriate follow-up.